Vaccination of mice and nonhuman primates using HIV-gene-containing DNA - PubMed (original) (raw)
Vaccination of mice and nonhuman primates using HIV-gene-containing DNA
M A Liu et al. Antibiot Chemother (1971). 1996.
No abstract available
Similar articles
- Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
Smith JM, Amara RR, McClure HM, Patel M, Sharma S, Yi H, Chennareddi L, Herndon JG, Butera ST, Heneine W, Ellenberger DL, Parekh B, Earl PL, Wyatt LS, Moss B, Robinson HL. Smith JM, et al. AIDS Res Hum Retroviruses. 2004 Jun;20(6):654-65. doi: 10.1089/0889222041217419. AIDS Res Hum Retroviruses. 2004. PMID: 15242543 - Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges.
Tang Y, Villinger F, Staprans SI, Amara RR, Smith JM, Herndon JG, Robinson HL. Tang Y, et al. J Virol. 2002 Oct;76(20):10147-54. doi: 10.1128/jvi.76.20.10147-10154.2002. J Virol. 2002. PMID: 12239289 Free PMC article. - Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
Boyer JD, Cohen AD, Ugen KE, Edgeworth RL, Bennett M, Shah A, Schumann K, Nath B, Javadian A, Bagarazzi ML, Kim J, Weiner DB. Boyer JD, et al. AIDS. 2000 Jul 28;14(11):1515-22. doi: 10.1097/00002030-200007280-00007. AIDS. 2000. PMID: 10983638 - Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina.
Galvin TA, Muller J, Khan AS. Galvin TA, et al. Vaccine. 2000 May 22;18(23):2566-83. doi: 10.1016/s0264-410x(99)00569-1. Vaccine. 2000. PMID: 10775791 - The non-env tropism of HIV/SIV (Review).
Shimano R, Inubushi R, Tamaki M, Akari H, Koyama AH, Adachi A. Shimano R, et al. Int J Mol Med. 1998 Nov;2(5):541-4. doi: 10.3892/ijmm.2.5.541. Int J Mol Med. 1998. PMID: 9858649 Review.
Cited by
- Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA, Charini WA, Kuroda MJ, Schmitz JE, Racz P, Tenner-Racz K, Manson K, Wyand M, Lifton MA, Nickerson CE, Fu T, Shiver JW, Letvin NL. Egan MA, et al. J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000. J Virol. 2000. PMID: 10906202 Free PMC article. - Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.
Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL. Barouch DH, et al. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4192-7. doi: 10.1073/pnas.050417697. Proc Natl Acad Sci U S A. 2000. PMID: 10759543 Free PMC article. - Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.
Wyatt LS, Belyakov IM, Earl PL, Berzofsky JA, Moss B. Wyatt LS, et al. Virology. 2008 Mar 15;372(2):260-72. doi: 10.1016/j.virol.2007.10.033. Epub 2007 Nov 28. Virology. 2008. PMID: 18048074 Free PMC article. - DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, Pavlakis GN. Rosati M, et al. J Virol. 2005 Jul;79(13):8480-92. doi: 10.1128/JVI.79.13.8480-8492.2005. J Virol. 2005. PMID: 15956591 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical